← Browse by Condition
Medical Condition
fatty liver
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for fatty liver sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — fatty liver Clinical Trials
How many clinical trials are currently recruiting for fatty liver?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for fatty liver, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for fatty liver?
fatty liver research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a fatty liver clinical trial?
Eligibility criteria for fatty liver trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06661655
Recruiting
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
Enrollment
120 pts
Location
France
Sponsor
E-Scopics
NCT07238985 Phase 1, Phase 2
Recruiting
Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
Enrollment
50 pts
Location
Egypt
Sponsor
Tanta University
NCT04371042
Recruiting
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Enrollment
5,000 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT06599918 Phase 2
Recruiting
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Enrollment
30 pts
Location
Spain
Sponsor
Fundació Institut de Recerca d...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology